| <strong>Whether to administer non–live attenuated vaccinations to patients receiving glucocorticoids or defer vaccination to a later time point to maximize vaccine immunogenicity</strong> | <strong>Low for pneumococcal vaccines, very low for other vaccines</strong> | PICO 4. In patients with RMD, does the immunogenicity or efficacy of vaccine Z differ in patients taking high‐dose steroids as compared to those taking lower doses of steroids or those not taking steroids? | 551–579